Using a closure analysis method to reduce CGT contamination risks
Many cell therapy manufacturing processes use open unit manipulations. As a result, they are at risk of potential contam...
Development Group
Viewing related articles
Implementation of PAT survey summary and vendor technical presentations
A BioPhorum member only benchmarking survey looking at the converting the implementation of PAT for Raman and flow VPE technologies
Pitfalls of using r-squared supporting information deck
A BioPhorum member only benchmarking survey looking at the similarities and differences between strategies of member companies on the qualification and validation of bioassays.
Forced degradation studies oxidation studies
The outcomes of several discussions on a survey conducted on forced degradation studies oxidation studies is available in this BioPhorum member only document.
Forced degradation study correlation to long term stability
A benchmarking survey looking at the Forced Degradation Study (FDS) correlation to long term degradation. It demonstrates the challenges in the area experienced by member companies.
Forced degradation studies for drug product (DP) (lyo change to liquid for late phase) to support comparability
A BioPhorum member only benchmarking survey looking at approaches on the use of forced degradation studies for drug product (lyo to liquid formulation swap).
Analytical method bridging study strategy survey
Key messages emerging following analysis of the survey are that bridging approaches differ between companies and there is lack of a harmonized approach outside a commercial setting. The Workstream are examining if a guidance paper would be beneficial.
Analytical challenges of polysorbate in biopharmaceutical formulations benchmarking survey webinar
A deep dive into polysorbates and their degradation pathways, analytical methods and the polysorbate control strategy.
BPDG32: PAT monitoring and control
Event report for BPDG32. The purpose of the meeting was too share learning on process analytical technologies and their application in process monitoring and control.
BPDG31: Process modulation on Selected CQAs
Event report for BPDG31, focusing mainly on host cell proteins with the objective of improving participant understanding the challenges, strategies and learnings companies have encountered and developed.
BPDG30: Drug product development
Event report of the 30th BioPhorum Development Group, bringing together 156 participants from 30 companies.